Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 781 to 795 of 1553 results for do not do recommendations

  1. Ravulizumab for treating paroxysmal nocturnal haemoglobinuria (TA698)

    Evidence-based recommendations on ravulizumab (Ultomiris) for treating paroxysmal nocturnal haemoglobinuria in adults.

    Technology appraisal guidance
    Published
    19 May 2021
    View recommendations

    Sections for TA698

  2. Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency (TA709)

    Evidence-based recommendations on pembrolizumab (Keytruda) for treating metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency in adults.

    Technology appraisal guidance
    Published
    23 June 2021
    View recommendations

    Sections for TA709

  3. How voluntary and community sector organisations can help us develop guidance

    How voluntary and community sector (VCS) organisations can help NICE develop guidance

  4. AEDs and pregnancy: What is the malformation rate and longer term neurodevelopmental outcome of children born to mothers who have taken AEDs during pregnancy?

    Recommendation ID CG137/5 Question AEDs and pregnancy: What is the malformation rate and longer term neurodevelopmental outcome of...

    Research recommendation
    Published
    13 August 2021

  5. Algorithms applied to spirometry to support the diagnosis of lung conditions in primary care and community diagnostic centres

    In development Reference number: GID-HTE10065 Expected publication date:  02 April 2026

    Health technology evaluations
    In development

  6. Who can register as a stakeholder?

    Find out more about the types of organisations that can register to be a stakeholder at NICE.

  7. Can GP practices deliver effective and cost effective condom schemes to reduce STIs?: -Can condom schemes be effective and cost effective in GP practices to reduce STIs? Can they be delivered in ways that are acceptable to GPs and other practice staff? In addition, how can the impact of such schemes be maximised?

    Recommendation ID NG68/5 Question Can GP practices deliver effective and cost effective condom schemes to reduce STIs?: -Can condom...

    Research recommendation
    Published
    12 October 2018

  8. Clean air zones:- How do different elements of a clean air zone interact to improve air quality and what is the overall effect on people's health?

    Recommendation ID NG70/3 Question Clean air zones:- How do different elements of a clean air zone interact to improve air...

    Research recommendation
    Published
    12 October 2018

  9. Supporting young people to manage their conditions:- What is the relationship between transition and subsequent self-management?

    Recommendation ID NG43/6 Question Supporting young people to manage their conditions:- What is the relationship between transition and

    Research recommendation
    Published
    21 March 2016

  10. Adding a newer anti-anginal drug to a calcium channel blocker:- What is the clinical and cost effectiveness of adding a newer anti-anginal drug (nicorandil, ivabradine or ranolazine) to a calcium channel blocker for treating stable angina?

    Recommendation ID CG126/1 Question Adding a newer anti-anginal drug to a calcium channel blocker:- What is the clinical and cost...

    Research recommendation
    Published
    9 June 2015

  11. Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)

    NICE has developed a medtech innovation briefing (MIB) on Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions .

    Medtech innovation briefing
    Published
    29 November 2016

  12. Treating small oesophageal varices:- Do non-selective beta-blockers improve survival and prevent first variceal bleeds in people with cirrhosis that is associated with small oesophageal varices?

    Recommendation ID NG50/2 Question Treating small oesophageal varices:- Do non-selective beta-blockers improve survival and...

    Research recommendation
    Published
    25 August 2016

  13. How effective and cost effective are lifestyle weight management programmes available in the UK over at least at least 3 to 5 years, and ideally beyond 10 years. Specifically: - Do short-term (12-week) interventions provide adults with the self-management skills they need to maintain weight loss in the long term? - Are alternative approaches to weight management (such as approaches that focus on a healthy lifestyle, behaviour change and the prevention of weight gain rather than weight loss) effective and cost effective in the long term? - How effective and cost effective are programmes for people of different ages, gender, sexuality or from different ethnic or socioeconomic groups? - How effective and cost effective are programmes for specific population groups, such as adults with depression or with disabilities?

    Recommendation ID PH53/2 Question How effective and cost effective are lifestyle weight management programmes available in the UK over

    Research recommendation
    Published
    9 June 2015

  14. How effective are lifestyle weight management programmes available in the UK, when directly compared using high-quality trials? In particular, what effect do specific components of a multicomponent lifestyle weight management programme have on adherence, effectiveness and cost effectiveness? This includes: - components, or combinations of components, that support weight loss or the prevention of weight regain - the effect of programme length, intensity, setting and means of delivery (examples of the latter include group, individual and remote support) - specific behaviour change techniques (using a recognised taxonomy) - the effect of new technologies - the effect of additional support services, such as self-help groups and networks approaches to commissioning - processes for collecting long-term follow-up data.

    Recommendation ID PH53/1 Question How effective are lifestyle weight management programmes available in the UK, when directly compared

    Research recommendation
    Published
    9 June 2015

  15. Newly diagnosed seizures (focal and generalised) – monotherapy: How do the newer AEDs compare in efficacy to the standard AEDs in the treatment of newly diagnosed epilepsy? Focal seizures: carbamazepine, eslicarbazepine acetate, lacosamide, lamotrigine, levetiracetam, pregabalin  and zonisamide. Generalised seizures: lamotrigine, levetiracetam, sodium valproate and zonisamide.

    Recommendation ID CG137/1 Question Newly diagnosed seizures (focal and generalised) – monotherapy: How do the newer AEDs...

    Research recommendation
    Published
    13 August 2021